Neurocrine biosciences announces third quarter results

Neurocrine biosciences reports third quarter 2019 financial results.q3 earnings per share $0.56.q3 earnings per share estimate $0.64 -- refinitiv ibes data.q3 revenue $222.1 million versus refinitiv ibes estimate of $211.6 million.as of september 30, co's cash & available-for-sale investments was $875 million.

NBIX Ratings Summary

NBIX Quant Ranking